By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
RAYOS Drug Profile
Email this page to a colleague
When do Rayos patents expire, and what generic alternatives are available?
Rayos is a drug marketed by Horizon Pharma Usa and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.
This drug has fifty-three patent family members in twenty-nine countries.
The generic ingredient in RAYOS is prednisone. There are sixteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the prednisone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rayos
A generic version of RAYOS was approved as prednisone by WATSON LABS on December 31st, 1969.
Summary for RAYOS
| International Patents: | 53 |
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Patent Applications: | 4,473 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for RAYOS |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for RAYOS |
| What excipients (inactive ingredients) are in RAYOS? | RAYOS excipients list |
| DailyMed Link: | RAYOS at DailyMed |
ATC Classes for RAYOS
Paragraph IV (Patent) Challenges for RAYOS
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| RAYOS | TABLET, DELAYED RELEASE;ORAL | prednisone | 202020 | 2012-11-26 |
US Patents and Regulatory Information for RAYOS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Pharma Usa | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-001 | Jul 26, 2012 | RX | Yes | No | Get Started Free | Get Started Free | Get Started Free | ||||
| Horizon Pharma Usa | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-002 | Jul 26, 2012 | RX | Yes | No | Get Started Free | Get Started Free | Get Started Free | ||||
| Horizon Pharma Usa | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-001 | Jul 26, 2012 | RX | Yes | No | Get Started Free | Get Started Free | Y | Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RAYOS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Horizon Pharma Usa | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-001 | Jul 26, 2012 | Get Started Free | Get Started Free |
| Horizon Pharma Usa | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-002 | Jul 26, 2012 | Get Started Free | Get Started Free |
| Horizon Pharma Usa | RAYOS | prednisone | TABLET, DELAYED RELEASE;ORAL | 202020-002 | Jul 26, 2012 | Get Started Free | Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RAYOS
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2006524229 | Get Started Free |
| China | 1777412 | Get Started Free |
| Denmark | 1631251 | Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
